| Bioactivity | AChRα(97-116) TFA, a peptide, can be used to induce experimental autoimmune myasthenia gravis (EAMG)[1] |
| Name | AChRα(97-116) TFA |
| Sequence | Asp-Gly-Asp-Phe-Ala-Ile-Val-Lys-Phe-Thr-Lys-Val-Leu-Leu-Asp-Tyr-Thr-Gly-His-Ile |
| Shortening | DGDFAIVKFTKVLLDYTGHI |
| Formula | C106H162N24O30.xC2HF3O2 |
| Molar Mass | 2252.56 (free acid) |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Cui YZ, et al. Enhancement of T Follicular Helper Cell-Mediated Humoral Immunity Reponses During Development of Experimental Autoimmune Myasthenia Gravis. Neurosci Bull. 2019 Jun;35(3):507-518. |
AChRα(97-116) TFA
CAS: F: C106H162N24O30.xC2HF3O2 W: 2252.56 (free acid)
AChRα(97-116) TFA, a peptide, can be used to induce experimental autoimmune myasthenia gravis (EAMG)
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.